These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23529728)
1. Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. Chamoun-Emanuelli AM; Pecheur EI; Simeon RL; Huang D; Cremer PS; Chen Z Antimicrob Agents Chemother; 2013 Jun; 57(6):2571-81. PubMed ID: 23529728 [TBL] [Abstract][Full Text] [Related]
2. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236 [TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503 [TBL] [Abstract][Full Text] [Related]
4. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes. Qian XJ; Zhang XL; Zhao P; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Zhu YZ; Qi ZT Sci Rep; 2016 Jun; 6():27268. PubMed ID: 27252043 [TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774 [TBL] [Abstract][Full Text] [Related]
7. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus. Chamoun-Emanuelli AM; Pécheur EI; Chen Z Antiviral Res; 2014 Sep; 109():141-8. PubMed ID: 25019406 [TBL] [Abstract][Full Text] [Related]
8. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process. Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669 [TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro. Hang X; Peng H; Song H; Qi Z; Miao X; Xu W J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793 [TBL] [Abstract][Full Text] [Related]
10. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain. Chi X; Niu Y; Cheng M; Liu X; Feng Y; Zheng F; Fan J; Li X; Jin Q; Zhong J; Li YP; Yang W Sci Rep; 2016 Apr; 6():25224. PubMed ID: 27121372 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives. Zhang KX; Qian XJ; Zheng W; Cai MC; Ma Y; Zhang DZ; Yu SC; Meng QG; Jin YS Med Chem; 2021; 17(9):974-982. PubMed ID: 32819233 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244 [TBL] [Abstract][Full Text] [Related]
14. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway. Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784 [TBL] [Abstract][Full Text] [Related]
15. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595 [TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803 [TBL] [Abstract][Full Text] [Related]
17. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176 [TBL] [Abstract][Full Text] [Related]
18. A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors. Banda DH; Perin PM; Brown RJP; Todt D; Solodenko W; Hoffmeyer P; Kumar Sahu K; Houghton M; Meuleman P; Müller R; Kirschning A; Pietschmann T J Hepatol; 2019 Jun; 70(6):1082-1092. PubMed ID: 30769006 [TBL] [Abstract][Full Text] [Related]
19. 5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry. Nguyen LP; Park C; Luong TTD; Park EM; Choi DH; Han KM; Mai HN; Nguyen HC; Lim YS; Hwang SB Sci Rep; 2019 May; 9(1):7288. PubMed ID: 31086268 [TBL] [Abstract][Full Text] [Related]
20. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry. Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]